Active Ingredient(s): Pyridostigmine
FDA Approved: * August 14, 1973
Pharm Company: * SANDOZ
Category: Myasthenic Syndrome

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Regonol Overview

Pyridostigmine is a medication used to treat myasthenia gravis[1] and underactive bladder[2]. It is also used together with atropine to end the effects of neuromuscular blocking medication of the non-depolarizing type.[3] It is typically given by mouth but can also be used by injection.[3] The effects generally begin within 45 minutes and last up to 6 hours.[3] Common side effects include nausea, diarrhea, frequen...

Read more Regonol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Regonol Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 5mg/ml
  • Syrup: 60mg/5ml
  • Tablet: 60mg
  • Tablet, Extended Release: 180mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Regonol: (1 result)

Sorted by National Drug Code
  • 0781-3040 Regonol 5 mg/ml Intravenous; Parenteral Injection, Solution by Sandoz Inc

Other drugs which contain Pyridostigmine or a similar ingredient: (2 results)